Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07181720 | CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors | suspended | Phase 1 | 90 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Sep 11, 2026 | clinicaltrials |
| NCT01083966 | Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma | suspended | Phase 1 | 30 | Northwell HealthOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT04266730 |
| Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab(PANDA-VAC) |
| suspended |
| Phase 1 |
| 6 |
| UNC Lineberger Comprehensive Cancer CenterOTHER |
| 1 |
| Apr 23, 2026 |
| clinicaltrials |
| NCT04840472 | Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer | suspended | Phase 1 | 28 | Stanford UniversityOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT03181035 | Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer(FAITH) | suspended | Phase 1 / Phase 2 | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | Aug 12, 2024 | clinicaltrials |
Data updated 19 days agoSource updated Sep 11, 2026source: clinicaltrials